PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Human insulin less temperature-sensitive than previously thought

A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration

2023-11-03
(Press-News.org) A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration. This affects millions of people living in low- and middle-income countries, particularly in rural areas, as well as people whose lives have been disrupted by conflict or natural disasters.

Human insulin is a hormone produced by the body that helps turn food into energy and controls blood sugar levels. People with diabetes cannot make enough insulin and those with type 1 diabetes have to inject insulin several times a day, typically before every meal. Insulin is an essential medicine for people with diabetes and current guidance states that before use it must be kept refrigerated to preserve its effectiveness.

For millions of people with diabetes living in low- and middle-income countries, however, the harsh reality is that electricity and refrigeration are luxuries that are unavailable to them. Vulnerable populations in war-torn areas, disaster-prone regions, and climate crisis-affected areas, including those enduring extreme heat, also need solutions that don’t rely on powered fridges.

The new Cochrane review summarizes results of different studies investigating what happens to insulin when stored outside of fridges, including previously unpublished data from manufacturers. The review found that it is possible to store unopened vials and cartridges of specific types of human insulin at temperatures of up to 25°C for a maximum of six months, and up to 37°C for a maximum of two months, without any clinically relevant loss of insulin activity. Data from one study showed no loss of insulin activity for specific insulin types when stored in oscillating ambient temperatures of between 25°C and 37°C for up to three months. This fluctuation resembles the day-night temperature cycles experienced in tropical countries.

The research team, led by Bernd Richter from the Institute of General Practice, Medical Faculty of the Heinrich-Heine-University in Düsseldorf, Germany, conducted comprehensive research to investigate insulin stability under various storage conditions. The review analyzed a total of seventeen studies, including laboratory investigations of insulin vials, cartridges/pens, and prefilled syringes, demonstrating consistent insulin potency at temperatures ranging from 4°C to 37°C, with no clinically relevant loss of insulin activity.

Bernd stressed the significance of this research, particularly for people living with type 1 diabetes, where "insulin is a lifeline, as their very lives depend on it. While type 2 diabetes presents its challenges, type 1 diabetes necessitates insulin for survival. This underscores the critical need for clear guidance for people with diabetes in critical life situations, which many individuals lack from official sources.

"Our study opens up new possibilities for individuals living in challenging environments, where access to refrigeration is limited. By understanding the thermal stability of insulin and exploring innovative storage solutions, we can make a significant impact on the lives of those who depend on insulin for their well-being."

These findings can help communities facing challenges in securing constant cold storage of insulin. They provide reassurance that alternatives to powered refrigeration of insulin are possible without compromising the stability of this essential medicine. It suggests that if reliable refrigeration is not possible, room temperature can be lowered using simple cooling devices such as clay pots for insulin storage.

The researchers have also identified uncertainties for future research to address. There remains a need to better understand insulin effectiveness following storage under varying conditions. Further research is also needed on mixed insulin, influence of motion for example when insulin pumps are used, contamination in opened vials and cartridges, and studies on cold environmental conditions.

END


ELSE PRESS RELEASES FROM THIS DATE:

Study reveals untapped potential to increase eye donations needed for sight-restoring surgeries

Study reveals untapped potential to increase eye donations needed for sight-restoring surgeries
2023-11-03
EMBARGOED: Not for Release Until 00:01 AM (UK Time) on Friday 3 November 2023 New research highlights the need for routine discussions about eye donation in end-of-life care clinical settings Less than four per cent of eligible patients in end-of-life care settings were asked to consider eye donation Patients had positive views about eye donation, but most did not know it could be an option for them Staff need training and guidance to support discussing eye donation with patients A new study has found there is significant scope to increase the number of eye donations from patients cared for in hospice and palliative care settings - donations which are desperately needed for ...

Penn Medicine researchers develop gene editing approaches for phenylketonuria treatment

2023-11-02
PHILADELPHIA— Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals’ genetic ancestry. PKU causes an amino acid—called phenylalanine (Phe)—to build up in the bloodstream. Uncontrolled PKU can lead to intellectual disability, psychiatric issues, and seizures. While current therapies can partially improve outcomes, they require meticulous, lifelong compliance that is very difficult for most patients. ...

Mount Sinai researchers detail mechanism of a key protein implicated in age-related brain dysfunction

Mount Sinai researchers detail mechanism of a key protein implicated in age-related brain dysfunction
2023-11-02
Mount Sinai researchers have shed valuable light on the mechanism of a key protein that regulates the plasticity and function of the hippocampus, a key brain region involved in memory and learning, and that decreases with age in mice. The team’s findings, published in Molecular Psychiatry, could pave the way for a better understanding of how the protein, known as tissue inhibitor of metalloproteinases 2 (TIMP2), could potentially be targeted in age-related disorders like Alzheimer’s disease to help restore ...

UH researcher tackles mysterious Z-RNA structure and its potential connection to diseases

UH researcher tackles mysterious Z-RNA structure and its potential connection to diseases
2023-11-02
University of Houston Assistant Professor of Biology and Biochemistry Quentin Vicens has been awarded a $1.2 million grant from the National Institute of General Medical Sciences to unravel the mystery of Z-RNA – an enigmatic RNA structure within our cells that plays a critical role in immune response. This work is in collaboration with the laboratory of Beat Vögeli, associate professor at the University of Colorado and co-recipient of the award. Vicens, Vögeli and their research teams are on a mission to understand how Z-RNA forms, how often it appears in our genetic material and what it means for ...

Different antibiotics’ effects on gut microbes may impact hypertensive organ damage

2023-11-02
Highlights In a preclinical study, altering the intestinal microbiome with narrow-spectrum antibiotics affected organ damage associated with hypertension. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 2, 2023) — New research in rodents indicates that altering gut microbes may affect the development of organ damage associated with hypertension. The findings will be presented at ASN Kidney Week 2023 November 1–November ...

Are sodium-glucose cotransporter-2 inhibitors safe for patients with diabetes and cancer?

2023-11-02
Highlights Investigators found that in patients with diabetes and cancer, sodium glucose cotransporter-2 inhibitors were associated with a higher risk of diabetic ketoacidosis and fracture and a lower risk of acute kidney injury and urinary tract infection compared with glucagon-like peptide 1 receptor agonists. Results from the study will be presented at ASN Kidney Week 2023, November 1–November 5. Philadelphia, PA (November 2, 2023) — Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes ...

Wildfire air pollution may increase risks of hospitalization and death among patients on dialysis

2023-11-02
Highlights Among individuals receiving in-center hemodialysis treatment in Washington, Oregon, and California, exposure to wildfire-related air pollution was associated with elevated risks of hospitalization and mortality. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 2, 2023) — In analyses of data from western US states, increases in wildfire-related air pollution around dialysis clinics were linked to higher rates of hospitalizations and deaths among patients. The research will be presented at ASN Kidney Week 2023 ...

Simple automated tool prompts physicians to screen patients with diabetes for kidney disease

2023-11-02
Highlights A tool that provides an automated prompt to physicians increased kidney disease screening in patients with type 2 diabetes. Results from the study will be presented at ASN Kidney Week 2023 November 1–November 5. Philadelphia, PA (November 2, 2023) — Investigators have implemented an automated health maintenance tool created by the National Kidney Foundation into electronic medical records to prompt primary care physicians to screen for chronic kidney disease (CKD) in adult patients ...

FSU researchers capture high-resolution images of magnesium ions interacting with CRISPR gene-editing enzyme

FSU researchers capture high-resolution images of magnesium ions interacting with CRISPR gene-editing enzyme
2023-11-02
The gene-editing technology known as CRISPR has led to revolutionary changes in agriculture, health research and more. In research published in Nature Catalysis, scientists at Florida State University produced the first high-resolution, time-lapsed images showing magnesium ions interacting with the CRISPR-Cas9 enzyme while it cut strands of DNA, providing clear evidence that magnesium plays a role in both chemical bond breakage and near-simultaneous DNA cutting. “If you are cutting genes, you don’t want to have only one strand of DNA broken, because the cell can repair it easily without editing. You want both strands to be broken,” said Hong ...

Online grocery shopping promotes less variety, fewer impulse buys

2023-11-02
ITHACA, N.Y. – Online grocery carts tend to include less variety and fewer fruits and vegetables than those in a trip to a brick-and-mortar supermarket – but online shoppers are less susceptible to unhealthy impulse buys, according to a new Cornell University study. In an analysis of nearly 2 million shopping trips, the researchers found that within a given household, Instacart baskets are more similar to each other from week to week than in-store carts, with more than twice as many overlapping items between successive trips to the same retailer. Nutritionally, however, ...

LAST 30 PRESS RELEASES:

Encoding human experience: Study reveals how brain cells compute the flow of time

New study: Deep-sea discovery shines light on life in the twilight zone

Brazilian fossils reveal jaw-dropping discovery in mammal evolution

Now we know why children with Down’s syndrome have higher risk of Leukemia

Emerging SARS-CoV-2 resistance after antiviral treatment

Semaglutide and opioid overdose risk in patients with type 2 diabetes and opioid use disorder

Bronze age lactobacillus genomes clarify kefir history

Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder

One in two El Niño events could be extreme by mid-century

Bacterial ‘flipping’ allows genes to assume different forms

Gladstone presents inaugural Sobrato prize in neuroscience to Yadong Huang, a pioneer of Alzheimer’s research

Manganese cathodes could boost lithium-ion batteries

To make fluid flow in one direction down a pipe, it helps to be a shark

Growing divide: Rural men are living shorter, less healthy lives than their urban counterparts

During NY Climate Week, Alex Zhavoronkov PhD, Founder and CEO of Insilico Medicine, talks about Gen AI applications in drug discovery, longevity and climate change solutions at AWS Climate Tech & AI F

First genome-wide comparison of vapers and smokers finds similar DNA changes linked to disease risk

International research challenge to tackle knowledge gaps in women’s cardiovascular health

Pipeline of new drug treatment for non-alcoholic fatty liver disease/metabolic dysfunction-associated steatotic liver disease

Kissick Family Foundation, Milken Institute announce $3 million in funding for frontotemporal dementia research

How does cancer spread? Follow the map

Shrinking AR displays into eyeglasses to expand their use

High academic award for economic geographer Ron Boschma

Study reveals mallards' flight responses ineffective in preventing vehicle collisions

Home- vs office-based narrowband UV-B phototherapy for patients with psoriasis

Major boost in carbon capture and storage essential to reach 2°C climate target

‘Invisible forest’ of algae thrives as ocean warms

How do rare genetic variants affect health? AI provides more accurate predictions

Replacing hype about artificial intelligence with accurate measurements of success

Researchers harness AI to repurpose existing drugs for treatment of rare diseases

Combination treatment improves response to immunotherapy for lung cancer

[Press-News.org] Human insulin less temperature-sensitive than previously thought
A new Cochrane review has found that insulin can be kept at room temperature for months without losing potency, offering hope to people living with diabetes in regions with limited access to healthcare or stable powered refrigeration